[Role of PKC in the pathogenesis of diabetic vascular complications].
Inoguchi
Toyoshi
T
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University.
Umeda
Fumio
F
D000818:Animals; D002986:Clinical Trials as Topic; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000209:etiology*; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000209:etiology*; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D008301:Maleimides / Q000627:therapeutic use; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D064546:Protein Kinase C beta; D012307:Risk Factors
D004791:Enzyme Inhibitors; D007211:Indoles; D007527:Isoenzymes; D008301:Maleimides; C099154:ruboxistaurin; D011493:Protein Kinase C; D064546:Protein Kinase C beta